Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yu Jeh Liu"'
Autor:
Ozan Berk Imir, Alanna Zoe Kaminsky, Qian-Ying Zuo, Yu-Jeh Liu, Ratnakar Singh, Michael J. Spinella, Joseph Irudayaraj, Wen-Yang Hu, Gail S. Prins, Zeynep Madak Erdogan
Publikováno v:
Nutrients, Vol 13, Iss 11, p 3902 (2021)
Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals utilized in various industrial settings and include products such as flame retardants, artificial film-forming foams, cosmetics, and non-stick cookware, among others. Epidemiological
Externí odkaz:
https://doaj.org/article/d5a3a6ac6a5247f4b3b8824544cdb761
Autor:
Qianying Zuo, Karen L. Chen, Alicia Arredondo Eve, Yu-Jeh Liu, Sung Hoon Kim, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Zeynep Madak-Erdogan
Publikováno v:
Nutrients, Vol 13, Iss 10, p 3334 (2021)
About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hor
Externí odkaz:
https://doaj.org/article/09e3a940dfab4019919dcfc301eb8b29
Autor:
Zeynep Madak Erdogan, Debu Tripathy, Akshara Singareeka Raghavendra, John D. O'Neill, Evelyn Aranda, Benita S. Katzenellenbogen, Yvonne Ziegler, Ben Ho Park, David J. Shapiro, Nicole Hwajin Park, Eylem Kulkoyluoglu-Cotul, Ozan Berk Imir, Jenny Drnevich, Christine Chien, Ashlie Santaliz Casiano, Yu-Jeh Liu, Ayca Nazli Mogol, Qianying Zuo
Supplementary Table from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fcbd670914710b64958120b07b5ee2
https://doi.org/10.1158/1541-7786.22528229.v1
https://doi.org/10.1158/1541-7786.22528229.v1
Autor:
Zeynep Madak Erdogan, Debu Tripathy, Akshara Singareeka Raghavendra, John D. O'Neill, Evelyn Aranda, Benita S. Katzenellenbogen, Yvonne Ziegler, Ben Ho Park, David J. Shapiro, Nicole Hwajin Park, Eylem Kulkoyluoglu-Cotul, Ozan Berk Imir, Jenny Drnevich, Christine Chien, Ashlie Santaliz Casiano, Yu-Jeh Liu, Ayca Nazli Mogol, Qianying Zuo
Estrogen receptor–positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer–related deaths. Most patients with ER+ metastatic breast cancer (MBC) undergo treatment with the estrogen receptor antagonist fulvestrant as standard of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b4132d6b56eba42f1eb12d4ae2f62b
https://doi.org/10.1158/1541-7786.c.6545651.v1
https://doi.org/10.1158/1541-7786.c.6545651.v1
Autor:
Alicia Arredondo Eve, Elif Tunc, Yu-Jeh Liu, Saumya Agrawal, Huriye Erbak Yilmaz, Sadık Volkan Emren, Filiz Akyıldız Akçay, Luidmila Mainzer, Justina Žurauskienė, Zeynep Madak Erdogan
Publikováno v:
Metabolites, Vol 11, Iss 6, p 339 (2021)
Coronary microvascular disease (CMD) is a common form of heart disease in postmenopausal women. It is not due to plaque formation but dysfunction of microvessels that feed the heart muscle. The majority of the patients do not receive a proper diagnos
Externí odkaz:
https://doaj.org/article/be2413be08de48f08fb6432841bf1e1a
Autor:
Sung Hoon Kim, John A. Katzenellenbogen, Benita S. Katzenellenbogen, Karen L. Chen, Alicia Arredondo Eve, Qianying Zuo, Yu Jeh Liu, Zeynep Madak-Erdogan
Publikováno v:
Nutrients
Volume 13
Issue 10
Nutrients, Vol 13, Iss 3334, p 3334 (2021)
Volume 13
Issue 10
Nutrients, Vol 13, Iss 3334, p 3334 (2021)
About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hor
Autor:
Yu-Jeh Liu, Ozan Berk Imir, David J. Shapiro, Yvonne S. Ziegler, Qianying Zuo, Jenny Drnevich, Evelyn Aranda, Zeynep Madak-Erdogan, Ashlie Santaliz Casiano, C. Chien, Debu Tripathy, N. H. Park, A. N. Mogol, Eylem Kulkoyluoglu-Cotul, Benita S. Katzenellenbogen, Ben Ho Park, A. S. Raghavendra, John D. O’Neill
Publikováno v:
Mol Cancer Res
Estrogen receptor-positive (ER+) metastatic tumors contribute to nearly 70% of breast cancer-related deaths. Most patients with ER+ metastatic breast cancer (MBC) undergo treatment with the estrogen receptor antagonist fulvestrant (Fulv) as standard-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194582c788d79991066b0614024b916a
https://doi.org/10.1101/2021.09.07.458711
https://doi.org/10.1101/2021.09.07.458711
Autor:
Filiz Akyıldız Akçay, Justina Žurauskienė, Saumya Agrawal, Alicia Arredondo Eve, Sadık Volkan Emren, Yu-Jeh Liu, Elif Tunc, Zeynep Madak Erdogan, Huriye Erbak Yilmaz, Luidmila Mainzer
Publikováno v:
Metabolites, Vol 11, Iss 339, p 339 (2021)
Metabolites
Volume 11
Issue 6
Metabolites
Volume 11
Issue 6
Coronary microvascular disease (CMD) is a common form of heart disease in postmenopausal women. It is not due to plaque formation but dysfunction of microvessels that feed the heart muscle. The majority of the patients do not receive a proper diagnos
Autor:
Zeynep Madak-Erdogan, Sadık Volkan Emren, Justina Zurauskiene, Huriye Erbak Yilmaz, Filiz Akyıldız Akçay, Yu-Jeh Liu, Elif Tunc, Luidmila Mainzer, Saumya Agrawal, Alicia Arredondo Eve
Publikováno v:
Journal of the Endocrine Society
Introduction: Coronary microvascular disease (CMD) affects small arteries that feed the heart and is more prevalent in postmenopausal women. Since CMD and Coronary artery disease (CAD) have distinct pathologies, but are treated the same way, the majo
Publikováno v:
IWAENC
We describe a private audio messaging system that uses echoes to unscramble messages at a few predetermined locations in a room. The system works by splitting the audio into short chunks and emitting them from different loudspeakers. The chunks are f